Latest News

Genesis MedTech initiates enrollment in its North American Early Feasibility Study using the J-Valve™ Transfemoral System for patients with severe aortic regurgitation

BURLINGAME, Calif., Oct. 23, 2023 /PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced initiation of enrollment in its North American Early Feasibility Study using its dedicated TAVR system, J-Valve™ Transfemoral (TF) System. The procedure was successfully perform...

2023-10-23 22:00 3070

Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis

MELBOURNE, Australia, Oct. 23, 2023 /PRNewswire/ -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, today announces that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation ...

2023-10-23 21:30 2455

Senmiao Technology Announces Ride-Hailing Platform Operating Metrics for September 2023

CHENGDU, China, Oct. 23, 2023 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao" or the "Company") (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry inChina as well as an operator of its own online ride-hailing platform, today announced the operating...

2023-10-23 21:15 2810

VUNO Secures FDA 510(k) Clearance for VUNO Med®-DeepBrain®

SEOUL, South Korea, Oct. 23, 2023 /PRNewswire/ -- VUNO Inc., South Korean medical AI company has received 510(k) clearance from the Food and Drug Administration (FDA) for its AI-powered brain quantification device, VUNO Med®-DeepBrain®.

2023-10-23 21:00 3717

COSMAX NBT Showcases Exclusive Materials and Formulations at SSW 2023, Strengthening its Presence in the U.S. Market

* Display microemulsion technology and plant-based formulation * Various exclusive materials prepared for skin health, wrinkles, and even hair health SEONGNAM, South Korea, Oct. 23, 2023 /PRNewswire/ -- COSMAX NBT, a global leading supplements ODM (original development manufacturing) company, ...

2023-10-23 21:00 3517

Zenerate Emerges Victorious GITEX Global's Supernova Challenge Pitch Competition, Redefining Sustainability and ESG in Real Estate

DUBAI, UAE, Oct. 23, 2023 /PRNewswire/ -- Zenerate, a pioneering AI proptech startup in the global real estate development industry, has clinched the top spot in GITEX Global's Supernova Challenge Pitch Competition. This victory underscores their commitment to advancing sustainability and driving...

2023-10-23 21:00 3076

Riiid's Paper on Enhancing Image Generation Accepted at NeurIPS 2023

SAN RAMON, Calif., Oct. 23, 2023 /PRNewswire/ -- Riiid, a global front-runner in AI-powered education solutions, has created innovative methods to enhance image-generation performance without increasing model size, even in resource-constrained GPU environments. The milestone is explained in a pap...

2023-10-23 21:00 2532

AI Diagnostic Platform Company Noul, unveils the result of Malaria study in Ethiopia and Ghana

* Reaffirming innovation as an AI-based digital microscope while presenting new malaria data at the annual meeting of the ASTMH 2023 * Noul's 'miLab™' showed significantly higher sensitivity than that of microscopy in health centers YONGIN, South Korea, Oct. 23, 2023 /PRNewswire/ -- Noul Co.,...

2023-10-23 21:00 3408

WAT Medical Donates to the Canadian Red Cross and Peach Arch Hospital

VANCOUVER, BC, Oct. 23, 2023 /PRNewswire/ -- WAT Medical Enterprise Ltd. has extended its support to two prominent institutions: the Canadian Red Cross and Peach Arch Hospital, throughmonetary donations. WAT Medical Enterprise Ltd. is a leading ...

2023-10-23 21:00 2639

Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day

SHANGHAI, Oct. 23, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that its Zhongxin platform  launched a WeChat mini program of Bre...

2023-10-23 20:00 2181

BACKND Expands into Global Market, Showcasing at Games on AWS 2023

* Game Backend SaaS BACKND to Showcase at 'Games on AWS 2023' * BACKND Strengthens its global presence through a robust partnership with AWS Korea. SEOUL, South Korea, Oct. 23, 2023 /PRNewswire/ -- AFI, the operator of BACKND, a SaaS platform for game backend, will participate in "Games on AWS...

2023-10-23 20:00 2522

WiMi Developed a Hybrid Bio-Signal-Based Brain-Computer Interface

BEIJING, Oct. 23, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that WiMi has developed a hybrid bios-signal-based brain-computer interface (HBS-BCI) that is rapidly g...

2023-10-23 20:00 2545

Live from ESMO 2023 | Oral Report Featuring Latest Data of Pelcitoclax (APG-1252) Combined with Osimertinib Demonstrates Potential as a New Treatment Option for TP53-and EGFR-Mutant NSCLC

SUZHOU, China and ROCKVILLE, Md., Oct. 23, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the latest clinical data of it...

2023-10-23 19:56 2218

HIGHWAY HOLDINGS REPORTS SECOND QUARTER FISCAL YEAR 2024 RESULTS

HONG KONG, Oct. 23, 2023 /PRNewswire/ -- Highway Holdings Limited (Nasdaq: HIHO, "the Company" or "Highway Holdings") today reported results for the second quarter of fiscal year 2024 and the six months endedSeptember 30, 2023. Reflecting the significantly negative impact of the post-COVID boom a...

2023-10-23 19:00 3588

Golden Heaven Group Holdings Ltd. Announces Approximately 10% Year-on-Year Traffic Growth during China's 2023 Mid-Autumn Festival and National Day Holidays

NANPING, China, Oct. 23, 2023 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven") (Nasdaq: GDHG), an amusement park operator in China, today announced that its five operational amusement parks attracted approximate 86,000 visitors during the 2023 Mid-Autumn Festiva...

2023-10-23 19:00 3762

Mabwell Announces Latest Clinical Progress and Data to be Reported on ESMO 2023 of 2 Novel Drugs

SHANGHAI, Oct. 23, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announces the latest clinical progress of 2 novel drugs including Nectin-4 ADC 9MW2821, as well as the clinical study data to be reported on ESMO 2023. Latest progress...

2023-10-23 18:25 2258

JINGHAO MEDICAL's self-fitting OTC hearing aids received FDA 510(k) approval

HONGKONG, SHANGHAI, and BEIJING, Oct. 23, 2023 /PRNewswire/ -- As the first hearing aid manufacturer to be listed in China, JINGHAO MEDICAL has once again taken a historic step. OnSeptember 26, 2023, the self-fitting OTC hearing aid developed and manufactured by JINGHAO MEDICAL officially receive...

2023-10-23 18:01 3342

Global Healthcare Accreditation Welcomes Karin Jay as President of Global Strategy and Announces Renée-Marie Stephano's Transition to CEO

New Leadership Aims to Reinforce GHA's Position as the Foremost Authority in Medical and Well-being Travel Accreditation PALM BEACH GARDENS, Fla., Oct. 23, 2023 /PRNewswire/ -- Global Healthcare Accreditation (GHA), the esteemed authority in accreditation and certification with a specialized foc...

2023-10-23 18:00 2606

JinkoSolar to Report Third Quarter 2023 Results on October 30, 2023

SHANGRAO, China, Oct. 23, 2023 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it plans to release its unaudited financial results for the third quarter e...

2023-10-23 17:52 3665

Sunvozertinib Demonstrates Best-in-Class Potential as a First-Line Treatment for EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer Patients

* Sunvozertinib monotherapy demonstrated superior efficacy and excellent safety in patients in the 1st line setting for advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Exon 20 insertion (Exon20ins) mutations, achieving a confirmed objective...

2023-10-23 17:34 2151